. Author manuscript; available in PMC: 2014 Aug 1.

Published in final edited form as: Mol Psychiatry. 2012 Jul 10;18(8):916–921. doi: 10.1038/mp.2012.100

Table 1.

Demographic, clinical, and radiochemical information of the study participants.

	Alcohol	Control	P value

Number of subjects	18	19
Age (years)	44 ± 10	40 ± 8	0.251
Body mass index (kg/m²)	27 ± 4	28 ± 5	0.738
Tobacco smokers/non-smokers (N)	11/7	2/17	0.001
Amount of alcohol use (drinks/day, TLFB)	18 ± 6	<1	<0.001
Alcohol Dependence Severity (ADS)	20 ± 6	<1	<0.001
Baseline craving (PACS)	12 ± 8	1 ± 2	<0.001
Baseline peak withdrawal (CIWA)	9 ± 5	N.A.	N.A.
Injected activity of [¹⁸F]FMPEP-d₂ (MBq)	187 ± 10	181 ± 12	0.103
Injected amount of [¹⁸F]FMPEP-d₂ (nmol)	1.7 ± 0.9	1.9 ± 0.8	0.547
Fraction of free [¹⁸F]FMPEP-d₂ in plasma (%)	0.38 ± 0.1	0.39 ± 0.2	0.886

Values are number, mean ± standard deviation, or range. N.A., not applicable.